HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Patterson, S Articles by McClenaghan, N H Search for Related Content PubMed PubMed Citation Articles by Patterson, S Articles by McClenaghan, N H

School of Biomedical Sciences, University of Ulster, Coleraine, BT52 1SA, UK
¹ Department of Biochemistry, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland

(Requests for offprints should be addressed to N H McClenaghan; Email: nh.mcclenaghan{at}ulster.ac.uk)

Elevated plasma homocysteine has been reported in individuals with diseases of the metabolic syndrome including vascular disease and insulin resistance. As homocysteine exerts detrimental effects on endothelial and neuronal cells, this study investigated effects of acute homocysteine exposure on ß-cell function and insulin secretion using clonal BRIN-BD11 ß-cells. Acute insulin release studies in the presence of various test reagents were performed using monolayers of BRIN-BD11 cells and samples assayed by insulin radioimmunoassay. Cellular glucose metabolism was assessed by nuclear magnetic resonance (NMR) analysis following 60-min exposure of BRIN-BD11 cell monolayers to glucose in either the absence or presence of homocysteine. Homocysteine dose-dependently inhibited insulin release at moderate and stimulatory glucose concentrations. This inhibitory effect was reversible at all but the highest concentration of homocysteine. ¹³C-glucose NMR demonstrated decreased labelling of glutamate from glucose at positions C2, C3 and C4, indicating that the tricarboxylic acid (TCA) cycle-dependent glucose metabolism was reduced in the presence of homocysteine. Homocysteine also dose-dependently inhibited insulinotropic responses to a range of glucose-dependent secretagogues including nutrients (alanine, arginine, 2-ketoisocaproate), hormones (glucagon-like peptide-1 (7–36)amide, gastric inhibitory polypeptide and cholecystokinin-8), neurotransmitter (carbachol), drug (tolbutamide) as well as a depolarising concentration of KCl or elevated Ca²⁺. Insulin secretion induced by activation of adenylate cyclase and protein kinase C pathways with forskolin and phorbol 12-myristate 13-acetate were also inhibited by homocysteine. These effects were not associated with any adverse action on cellular insulin content or cell viability, and there was no increase in apoptosis/necrosis following exposure to homocysteine. These data indicate that homocysteine impairs insulin secretion through alterations in ß-cell glucose metabolism and generation of key stimulus-secretion coupling factors. The participation of homocysteine in possible ß-cell demise merits further investigation.

This article has been cited by other articles:

				M. Y. Ali, M. Whiteman, C.-M. Low, and P. K Moore Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway J. Endocrinol., October 1, 2007; 195(1): 105 - 112. [Abstract] [Full Text] [PDF]

				P. Newsholme, L. Brennan, and K. Bender Amino Acid Metabolism, {beta}-Cell Function, and Diabetes Diabetes, December 1, 2006; 55(Supplement_2): S39 - S47. [Abstract] [Full Text] [PDF]